Many companies aside from Lilly and Novo Nordisk are also jumping on the train, testing their own GLP-1s in clinical trials, which could help with shortages in the future
System X(c) (-)/GSH/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
At each intervention, participants were titrated up to 1 mg or the maximum tolerated dose of semaglutide or placebo over 11 weeks, followed by the use of an automated insulin delivery system for 4 weeks
Meanwhile, countries in Asia, such as Singapore, South Korea, and China, are rapidly expanding biologics and biosimilar manufacturing capacity, offering scalability, speed, and growing technical sophistication, often supported by strong government investment
J., El Essawy, B., Jang, J., Loretelli, C., DAddio, F., Berra, C., Ben Nasr, M., Zuccotti, G., & Fiorina, P